Literature DB >> 25988856

New insights into heterogeneity of peritoneal B-1a cells.

Hongsheng Wang1, Jian-xin Lin2, Peng Li2, Jeff Skinner3, Warren J Leonard2, Herbert C Morse1.   

Abstract

Peritoneal B-1a cells are characterized by their expression of CD5 and enrichment for germline-encoded IgM B cell receptors. Early studies showing expression of a diverse array of VDJ sequences among purified B-1a cells provided a molecular basis for understanding the heterogeneity of the B-1a cell repertoire. Antigen-driven positive selection and the identification of B-1a specific progenitors suggest multiple origins of B-1a cells. The introduction of new markers such as PD-L2, CD25, CD73, and PC1 (plasma cell alloantigen 1, also known as ectonucleotide phosphodiesterase/pyrophosphatase 1) further helped to identify phenotypically and functionally distinct B-1a subsets. Among many B-1a subsets defined by these new markers, PC1 is unique in that it subdivides B-1a cells into PC1(hi) and PC1(lo) subpopulations with distinct functions, such as production of natural IgM and gut IgA, response to the pneumococcal antigen PPS-3, secretion of interleukin-10, and support for T helper 1 (TH 1) cell differentiation. RNA sequencing of these subsets revealed differential expression of genes involved in cellular movement and immune cell trafficking. We will discuss these new insights underlying the heterogeneous nature of the B-1a cell repertoire. Published 2015. This article is U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  B-1a; IL-10; PC1; lymphocyte trafficking

Mesh:

Year:  2015        PMID: 25988856      PMCID: PMC4651667          DOI: 10.1111/nyas.12791

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  76 in total

1.  B1-B cells are the main antigen presenting cells in CpG-ODN-stimulated peritoneal exudate cells.

Authors:  Hiromichi Bamba; Hirohito Ishigaki; Hideaki Ishida; Kiichi Kajino; Yoshihide Fujiyama; Kazumasa Ogasawara
Journal:  Microbiol Immunol       Date:  2005       Impact factor: 1.955

2.  All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes.

Authors:  H Masmoudi; T Mota-Santos; F Huetz; A Coutinho; P A Cazenave
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

3.  A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family.

Authors:  R R Hardy; C E Carmack; S A Shinton; R J Riblet; K Hayakawa
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

4.  Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection.

Authors:  C A Pennell; T J Mercolino; T A Grdina; L W Arnold; G Haughton; S H Clarke
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

5.  Ontogeny of terminal deoxynucleotidyl transferase-positive cells in lymphohemopoietic tissues of rat and mouse.

Authors:  K E Gregoire; I Goldschneider; R W Barton; F J Bollum
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

6.  Differential preferences in serosal homing and distribution of peritoneal B-cell subsets revealed by in situ CFSE labeling.

Authors:  Arpád Lábadi; Péter Balogh
Journal:  Int Immunol       Date:  2009-07-22       Impact factor: 4.823

7.  PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.

Authors:  Xuemei Zhong; Joseph R Tumang; Wenda Gao; Chunyan Bai; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

Review 8.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

9.  Kinetics of peritoneal B-1a cells (CD5 B cells) in young adult mice.

Authors:  G J Deenen; F G Kroese
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

10.  Activation and trafficking of peritoneal B1a B-cells in response to amphibole asbestos.

Authors:  Jean C Pfau; Kristina Hurley; Cody Peterson; Lindsey Coker; Cody Fowers; Ryan Marcum
Journal:  J Immunotoxicol       Date:  2013-06-07       Impact factor: 3.000

View more
  6 in total

1.  Refractory ascites in systemic lupus erythematosus: further biological support of intraperitoneal steroid treatment as a suitable therapeutical option.

Authors:  Yemil Atisha-Fregoso; Diego F Hernández-Ramírez; Elizabeth Olivares-Martínez; Carlos A Núñez-Alvarez; Luis Llorente; Gabriela Hernández-Molina
Journal:  Clin Rheumatol       Date:  2016-11-09       Impact factor: 2.980

2.  Plasma cell alloantigen ENPP1 is expressed by a subset of human B cells with potential regulatory functions.

Authors:  Jeongheon Yoon; Hongsheng Wang; Yong Chan Kim; Momoko Yoshimoto; Sadia Abbasi; Herbert C Morse Iii
Journal:  Immunol Cell Biol       Date:  2016-03-31       Impact factor: 5.126

3.  Prolonged Deleterious Influences of Chemotherapeutic Agent CPT-11 on Resident Peritoneal Macrophages and B1 Cells.

Authors:  Wen-Jing Bai; Chen-Guang Li; Cheng-Cheng Zhang; Li-Hui Xu; Qiong-Zhen Zeng; Bo Hu; Zhou Hong; Xian-Hui He; Dong-Yun Ouyang
Journal:  Front Immunol       Date:  2018-01-05       Impact factor: 7.561

4.  Defining Natural Antibodies.

Authors:  Nichol E Holodick; Nely Rodríguez-Zhurbenko; Ana María Hernández
Journal:  Front Immunol       Date:  2017-07-26       Impact factor: 7.561

5.  PD-L1/PD-L2-expressing B-1 cells inhibit alloreactive T cells in mice.

Authors:  Takayuki Hirose; Yuka Tanaka; Asuka Tanaka; Hiroshi Sakai; Yu Sasaki; Nobuo Shinohara; Hideki Ohdan
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

6.  B-1a cells acquire their unique characteristics by bypassing the pre-BCR selection stage.

Authors:  Jason B Wong; Susannah L Hewitt; Lynn M Heltemes-Harris; Malay Mandal; Kristen Johnson; Klaus Rajewsky; Sergei B Koralov; Marcus R Clark; Michael A Farrar; Jane A Skok
Journal:  Nat Commun       Date:  2019-10-18       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.